News about Global Pharma

Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s

Aranscia announced a partnership to develop novel biomarkers and a personalized medication management solution for the effective use of GLP-1 medications.

Global Pharma | 20/06/2024 | By Manvi |  369

Corealis Launches New Facilities in Laval Science Park

Corealis Pharma Inc. has expanded its facilities nestled in the heart of Laval's Biotech City, in the presence of the esteemed Christopher Skeete, Minister for the Economy, and Christine Poirier, Laval City Councillor.

Global Pharma | 20/06/2024 | By Aishwarya |  581

Zynext Ventures, the VC arm of Zydus Lifesciences, Announces Investment in Promaxo

Zynext Ventures USA LLC (Zynext Ventures), the Venture Capital (VC) arm of Zydus Lifesciences announced its investment in Promaxo Inc. (Promaxo).

Global Pharma | 19/06/2024 | By Manvi |  1371

ALPLA Group Announces Acquisition of Heinlein Plastik-Technik

The ALPLA Group has been expanding its pharma division ALPLApharma with the acquisition of Heinlein Plastik-Technik GmbH.

Global Pharma | 19/06/2024 | By Manvi |  732

TechInvention Lifecare Bags Start-up 50: The Trailblazers Award

TechInvention Lifecare Pvt. Ltd. has secured the coveted 'Start-up 50: The Trailblazers Award' at the 2nd edition of the "Dun & Bradstreet LEAP India Startup Summit 2024," held at the Taj Bangalore.

Global Pharma | 19/06/2024 | By Aishwarya |  395

YolTech and KACTUS to Accelerate DNA Editing System in Greater China

YolTech has teamed up with KACTUS to advance the commercialization of YolTech's proprietary DNA editor, YolCas12, in Greater China.

Global Pharma | 19/06/2024 | By Aishwarya |  498

Haemonetics Releases Limited Market Release for New VASCADE MVP XL Vascular Closure Device

Haemonetics Corp. has rolled out a limited market release of its new VASCADE MVP XL mid-bore venous closure device.

Global Pharma | 19/06/2024 | By Aishwarya |  931

Ascidian Partners with Roche for Development of RNA Exon Editing Therapeutics

Ascidian Therapeutics has signed a research collaboration and licensing agreement with Roche for the discovery and development of RNA exon editing therapeutics targeting neurological diseases.

Global Pharma | 19/06/2024 | By Aishwarya |  447

Thermo Fisher Scientific Unveils New Clinical Research Laboratory in Wisconsin

Thermo Fisher Scientific’s PPD clinical research business has launched a new clinical research laboratory building at its good manufacturing practices (GMP) lab in Middleton, Wisconsin.

Global Pharma | 19/06/2024 | By Aishwarya |  617

Spyre Announces First Participants Dosed in Phase 1 Trial of SPY001

Spyre Therapeutics, Inc. announced that it has initiated dosing of healthy volunteers in its first clinical trial of SPY001, an investigational novel half-life extended anti-α4β7 monoclonal antibody.

Global Pharma | 18/06/2024 | By Manvi |  334